Philips spends nearly $3bn to integrate Biotelemetry

At $2.8bn, Philips’s acquisition of the IT-enabled patient-monitoring company Biotelemetry, announced today, is its largest medtech takeover since the Dutch group bought Respironics for $5.1bn 12 years ago. Big as it is – by Philips’s standards – the deal is certainly a good fit with the company's recent M&A activity.